Where Pharma and
Patients Come Together
to Transform Care

250+ Attendees

25+ Pharma Case Studies

20+ Patient Speakers

10+ Roundtables

It’s pharma’s turn to inspire.

While some leaders have doubled down on patient centricity, elevating the function to the executive committee, our research has revealed warning signs of fatigue. Across patient centricity veterans, to those not yet convinced, people are frustrated that year after year we return to the same issues. The reality is: without concrete progress, patient centricity could lose steam, and pharma may fail to seize it’s biggest opportunity for patient value.

At a moment in which our research is also uncovering promising stories of progress, concrete improvements through digital innovation, and the development of robust models to demonstrate ROI, it would be a huge collective failure to ignore how far we’ve come. The way we see it is the conversation must catch up to the progress that we are seeing on the ground. Our commitment for the next edition of the Patient Summit USA is to cut the rhetoric and lay out a concise roadmap for action.

I attend eyeforpharma every year: they truly know what pharma companies need to do, to serve patients. Gitte Aabo
CEO, LEO Pharma

Partner or perish:
How pharma and patient groups must work together – or become irrelevant

Patient as co-designer:
How open innovation can transform R&D and PSPs whilst enabling patients to support you

Recruitment, resolved:
How patient co-created trials can rethink research and embed value

Technology and culture as one:
Adopt the can-do mindset of digital health startups, differentiate your brands and overdeliver on outcomes

Sneak-peek of the 2019 Speaker Line-up

efp award winner
Molly MacDonald

The Pink Fund

Molly MacDonald

Founder, CEO


 
Magdalena Schoeneich

Takeda

Magdalena Schoeneich

Global Head of Takeda Digital Accelerator, R&D



 
Laurie Myers

Merck

Laurie Myers

Global Health Literacy Director


 
John Linnell

John Linnell

COPD Patient, Patient Advocate



 
Laurie Meyers

Genentech

Laurie Meyers

Head of Patient Engagement


 
Hollie Schmidt

Accelerated Cure Project for MS

Hollie Schmidt

Vice President, Scientific Operations




5 years ago, I connected with Paul Simms at eyeforpharma. After our first conversation, I was actually shaking... could it be possible that someone had actually crafted an event that included all areas of the healthcare space AND embraced the patient perspective? He had, and it was an honour and privilege to attend. This year, I am in awe of the progress that has been made. The patient voice is loud, strong and utterly respected. Please lend your voice to this wonderful chorus of compassion. Heidi Floyd
Patient Advocate
You guys up your game every time. An amazing conference where leaders at all levels can share, learn, grow and develop. Jennifer Muszik
Biogen

4 Reasons to Attend:

  • Case Studies: Practical, tangible advice and actions from your peers which you can put into practise in your own company
  • Patient & Pharma Collaboration: Co-presentations with Pharma and patients to share real examples of collaboration.
  • Team Benefits: Group rates are now available for 2+ attendees, to ensure all interested peers can take advantage of this learning opportunity
  • All Stakeholders in one room: Working together to ensure we are engaging in solution focused exchanges across all departments

Exceptional Networking Opportunities

You’d be hard pushed to find better pharma networking anywhere in the world, beyond eyeforpharma Patient Summit USA. It is the only place to connect with real innovators and decision-makers

Connect:

With 250 executives working in Patient roles, digital, patient associations and patients themselves.

Network:

15+ hours of peer-to-peer networking, and a dazzling networking drinks reception

Meetings:

A slick messaging service on the event app, connecting delegates one-to-one to ensure you meet those whose goals you share

Interactivity:

Over 10 interactive roundtable discussions moderated by industry experts

Meet the industry’s decision makers

Statistics graphic; bar chart

Do business with this cross-section of pharma


Statistics graphic; pie chart

What Delegates are Saying…

of our attendees call our sessions “essential” to their future success

of our attendees say they will likely return next year

of our attendees rated the program very well run

Josh Bramwell

Josh Bramwell
Global Project Director
eyeforpharma

+44 (0) 207 375 7203
jbramwell@eyeforpharma.com

Don’t pay lip-service to patient centricity.
Make it happen.